: iStockAnalyst.com Symbols Feed

China Shenghuo Resumes Trading; Price Drops 50%

Tue, 09 Dec 2008 18:59:00 GMT

China Shenghuo Pharmaceutical Holdings (??????(??)????) has resumed trading on the NYSE Alternext US exchange. In early action, the price of its shares was cut in half, dropping 98 cents (52%) to $.91. The company’s stock was suspended from trading in late August because China Shenghuo was late in filing its financial statements. The company was forced to restate its previous reports when it discovered falsified records. More details... Stock Symbol: (NYSE Alternext US: KUN)[More...]

China Shenghuo Completes Restatement; Issues Q3 Report

Sat, 22 Nov 2008 16:53:00 GMT

China Shenghuo Pharmaceutical Holdings released its Q3 financial report and also announced that it has completed restatement of financial results for 2007 and the first two quarters of 2008. Most notable was the restatement in 2007’s net income, which dropped by a very significant $2.3 million, taking it down to $1.7 million. In Q3, revenues climbed 73%, but net income dropped. More details... Stock Symbol: (AMEX: KUN)[More...]

China Shenghuo to Restate Financial Results

Wed, 20 Aug 2008 18:28:00 GMT

China Shenghuo Pharmaceutical Holdings, Inc. will restate its financial reports from the past twelve months, saying that the company has discovered errors in sales commission advances and trade receivables. The Audit Committee and an independent counsel w[More...]

Dangers of Shorting Hot Oil Stocks

Wed, 21 May 2008 20:54:31 GMT

That title is just about the worst combo there is and yet I went full steam ahead, shorting 1,000 FPP five minutes after the market open into a spike I thought to be ill-fated. Nearly right away when...[More...]

China Shenghuo Reports Flat Revenues

Wed, 09 Apr 2008 06:33:18 GMT

China Shenghuo Pharmaceutical Holdings, Inc. released its 2007 financial statement last week, reporting that its net earnings were...[More...]

China Shenghuo Reports Unaudited Financial Results for the Second Quarter of 2009

Sat, 15 Aug 2009 03:54:00 GMT

China Shenghuo Pharmaceutical Holdings, Inc. , which is engaged in the research, development, manufacture, and marketing of pharmaceutical, nutritional supplement and cosmetic products in the People's Republic of China , today reported unaudited financial results for the second quarter ended June 30, 2009.[More...]

China Shenghuo Reports Unaudited Financial Results for the First Quarter of 2009

Fri, 15 May 2009 19:56:00 GMT

China Shenghuo Reports Year 2008 Financial Results

Wed, 01 Apr 2009 11:57:00 GMT

China Shenghuo Pharmaceutical Holdings, Inc. , reported financial results for the year ended December 31, 2008.[More...]

China Shenghuo Announces Management Expansion and Enhanced Internal Controls

Wed, 04 Mar 2009 11:46:00 GMT

KUNMING, China, March 4 /PRNewswire-Asia-FirstCall/ -- China Shenghuo Pharmaceutical Holdings, Inc. (NYSE Alternext US: KUN) ("China Shenghuo" or the "Company"), today announced the expansion of its senior management team to better align with the Company's business outlook, to optimize operations, and increase efficiencies across the organization.
The Company expanded the number of senior management personnel from 5 to 9 in preparation for the anticipated growth in its sales and operations.
Furthermore, the Company recently appointed two new independent directors to the Company's Board of Directors.

[More...]

China Shenghuo Receives Notice From NYSE Alternext US Regarding Listing Standards

Tue, 17 Feb 2009 20:57:00 GMT

KUNMING, China, Feb. 17 /PRNewswire-Asia-FirstCall/ -- China Shenghuo Pharmaceutical Holdings, Inc. (NYSE Alternext US: KUN) ("China Shenghuo" or the "Company"), today announced that on February 10, 2009, it received a deficiency letter from the NYSE Alternext US LLC ("NYSE Alternext US" or the "Exchange") stating that the Company was not in compliance with Section 704 of the Exchange's continued listing standards due to the Company's failure to hold an annual meeting of stockholders in 2008.
The Company was given an opportunity to submit a plan of compliance (a "Plan") to the Exchange by March 10, 2009 to demonstrate the Company's ability to regain compliance with Section 704 by August 11, 2009.
Because the Company restated certain of its financial statements during November 2008, the Company was unable to deliver its annual report and proxy statement to its stockholders during 2008.

[More...]

China Shenghuo to Resume Trading on NYSE Alternext US LLC

Tue, 09 Dec 2008 13:16:00 GMT

China Shenghuo Pharmaceutical Holdings, Inc. , today announced that the Company's shares would resume trading on NYSE Alternext US LLC at the open of business on Tuesday, December 9th. The Company's shares will continue to trade under the symbol "KUN."[More...]

China Shenghuo Announces Additional Roll-Out of '12 Ways' Cosmetics Products to Watsons Stores

Tue, 09 Dec 2008 12:26:00 GMT

China Shenghuo Pharmaceutical Holdings, Inc. , today announced that the Company is expanding its herbal-based "12 Ways" cosmetics products into additional Watsons Personal Stores in strategic markets in Mainland China.[More...]

China Shenghuo Announces Restated Results For Full Year 2007 & First Quarter 2008, Reports Results For Second & Third Quarter 2008

Thu, 20 Nov 2008 16:55:00 GMT

China Shenghuo Pharmaceutical Holdings, Inc. , today announced that, consistent with its previous announcements, it has filed with the United States Securities and Exchange Commission an amended Annual Report on Form 10-KSB/A for the year ended December 31, 2007, an amended Quarterly Report on Form 10-Q/A for the first quarter ended March 31, 2008 and Quarterly Reports on Form 10-Q for the second quarter ended June 30, 2008 and the third quarter ended September 30, 2008.[More...]

China Shenghuo Announces Results of Independent Audit Committee Investigation and Appointment of New CFO

Fri, 14 Nov 2008 16:56:00 GMT

China Shenghuo Pharmaceutical Holdings, Inc. , today announced the findings from its Audit Committee's previously announced independent internal investigation into the Company's accounting for certain sales representative commission advances and trade receivables, and other financial reporting matters.[More...]

NYSE Alternext US Accepts China Shenghuo's Compliance Plan for Continued Listing

Wed, 12 Nov 2008 12:26:00 GMT

China Shenghuo Pharmaceutical Holdings, Inc. , which is engaged in the research, development, manufacture, and marketing of pharmaceutical, nutritional supplement and cosmetic products in the People's Republic of China, today announced that the NYSE Alternext US LLC has accepted the Company's plan of compliance for continued listing.[More...]

Form 3 SUN XIAOBO For: Mar 16 (10K)

Thu, 26 Mar 2009 20:10:00 GMT

[More...]

Form 3 FU WENDY For: Nov 10 (10K)

Fri, 19 Dec 2008 19:00:00 GMT

[More...]

Form 3 ZHANG JASON YUANXIN For: Oct 29 (10K)

Fri, 19 Dec 2008 18:08:00 GMT

[More...]